Sepsis often proves difficult to diagnose as it comes on quickly and can be easily confused with other conditions. Failure to identify and treat the condition in a timely manner can have deadly consequences. However, properly assessing patients for their individualized risk of sepsis could help improve outcomes.
Data platforms that use predictive analytics can be implemented in the early identification of patients at high risk for sepsis. Orlando Health — a large health system that serves nearly 2 million people annually — and Vigilanz Intelligence have partnered to apply predictive models through the Vigilanz platform to promote the early identification of patients at risk for sepsis.
On Jan. 26, Eric Rose, Pharm. D, manager in corporate clinical decision support at Orlando Health, will join Adam Klass, chief technology officer with VigiLanz, and Bart Abban, PhD, director of analytics and data science with VigiLanz, to discuss the development of predictive models for sepsis risk and how such models can improve outcomes. The speakers will also share an update from a pilot program for the identification patients at risk for sepsis.
To learn more and register for the webinar, click here.
More articles on infection control:
Top 10 infection control stories, Jan. 16-20
Tennessee health commissioner expresses concern over Arkansas mumps outbreak
200 college students sickened with norovirus in Toronto
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
